Exelixis FDA approval barred until at least Jan 15, 2030
Exelixis won an appeals court ruling upholding key patents, with FDA approval barred until at least Jan 15, 2030.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.